Emerging Disease News and Research

RSS

Hong Kong health commitment pledged in Sweden

The SARS crisis was a reminder of the need for a strong commitment to enhancing public health infrastructure and global co-operation against communicable diseases.

28 Sep 2004

Global health is recurrently being threatened by new and re-emerging infectious diseases

Global health is recurrently being threatened by new and re-emerging infectious diseases. Examples of new and re-emerging infectious diseases include SARS (Severe Acute Respiratory Syndrome), new variant CJD (Creutzfeldt-Jakob Disease), avian flu and Ebola.

20 Sep 2004

WHO calls enhanced preparedness for SARS and avian influenza

The World Health Organization (WHO) has urged countries to put in place preventive measures and enhance preparedness ready for the possible re-emergence of SARS (severe acute respiratory syndrome) and avian influenza A (H5N1) in humans.

14 Sep 2004

Scientists have traced the first steps in the way some new diseases emerge

Scientists have traced the first steps in the way some new diseases emerge, and how harmless bacteria living in insects become dangerous disease-causing bugs which can affect humans, like the plague or anthrax.

8 Sep 2004

New book predicts a "vaccine century"

A new book published by the Pan American Health Organization (PAHO) predicts that the 21st century will become the "century of vaccines" thanks to rapid developments in the field of immunization.

21 Jul 2004

Research team developing new defenses against plague and smallpox

Using a federal biodefense grant, a Wake Forest University Baptist Medical Center team will try to develop new approaches to immunizing people against the plague and smallpox, two of the most feared potential agents of bio-terrorism.

15 Jul 2004

Possible new type of zoonose in England

A short item was considered by the UK Zoonoses Group on a nervous condition in a heifer which had suffered partial leg paralysis. It was initially diagnosed as suspected botulism.

9 Jun 2004

FDA finalizes new rule on donor eligibility for human tissues and cells

FDA today published a final rule establishing donor eligibility criteria for donors of human cells, tissues, and cellular and tissue-based products (HCT/Ps) to help prevent the transmission of communicable disease when these products are transplanted.

20 May 2004

The UK Health Protection Agency has issued symptom-based clinical action cards to all GPs in England to help them recognise unusual symptoms

The Health Protection Agency has this week issued symptom-based clinical action cards to all GPs in England to help them recognise unusual symptoms. The cards do not reflect any increased threat to the public, but have been developed in response to requests from the medical profession for more specific training in the recognition of unusual symptoms caused by emerging diseases and by chemical, biological, radiological and nuclear (CBRN) hazards.

18 May 2004

21st century is shaping up to be the "century of vaccines"

The 21st century is shaping up to be the "century of vaccines," as vaccine developers make striking progress against both emerging and longstanding diseases, according to Vaccines: Preventing Diseases and Protecting Health, from the Pan American Health Organization (PAHO).

14 Apr 2004

Bird flu in humans highlights vulnerability of people to emerging diseases

The occurrence of avian influenza in humans is a reminder of the vulnerability of people to an emerging pandemic, Mayo Clinic researchers warn in the current issue of Mayo Clinic Proceedings.

13 Apr 2004

A new technique for engineering protein crystals is helping scientists figure out the three-dimensional structures of some important biological molecules

A new technique for engineering protein crystals is helping scientists figure out the three-dimensional structures of some important biological molecules, including a key plague protein whose structure has eluded researchers until now. The technique, developed with support from the National Institute of General Medical Sciences (NIGMS) of the National Institutes of Health (NIH), promises to help pharmaceutical companies develop more effective drugs to treat various diseases by tailor-making molecules to "fit" a protein's shape.

6 Apr 2004